Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Vici is an end-to-end pharmaceutical research and development company specializing in taking projects from pre-clinical research through the Phase 2 stage of FDA approval.
Lead Product(s): Undisclosed
Therapeutic Area: Psychiatry/Psychology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Psycheceutical
Deal Size: $10.5 million Upfront Cash: $10.5 million
Deal Type: Acquisition August 16, 2022